Deep Medicine Acquisition Corp. (DMAQ) Research

Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic efforts are specifically concentrated on identifying promising enterprises within the healthcare industry. Incorporated in 2020, DMAQ maintains its principal place of business in New York, New York.

Market snapshot

Symbol
DMAQ
Price
$2.96
Day change
-64.72%
Market cap
$723.0K
P/E ratio
-0.03x
52-week range
2.96-19.91
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Acri Capital Acquisition Corporation (ACAC)
  • AfterNext HealthTech Acquisition Corp. (AFTR-UN)
  • Ahren Acquisition Corp. (AHRN)
  • ALSP Orchid Acquisition Corporation I (ALOR)
  • Alpha One Inc. (AOAO)
  • Altimar Acquisition Corp. III (ATAQF)
  • AlphaVest Acquisition Corp (ATMV)
  • Achari Ventures Holdings Corp. I (AVHI)

Recent insider activity

  • Bright Vision Sponsor LLC — J-Other (150000 shares) on 2023-10-31
  • Chiang John — trade on 2022-10-15
  • Chiang John — trade (0 shares) on 2022-10-15
  • POLANEN HUMPHREY P — trade (0 shares) on 2021-10-26
  • Bright Vision Sponsor LLC — J-Other (406500 shares) on 2021-10-29

Open Deep Medicine Acquisition Corp. (DMAQ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.